Back to top
more

Henry Schein (HSIC)

(Real Time Quote from BATS)

$69.00 USD

69.00
2,186,498

-3.33 (-4.60%)

Updated Nov 5, 2024 03:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Dental Supplies

Zacks News

Is Henry Schein (HSIC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Quest Diagnostics (DGX) Introduces New Post-COVID-19 Panels

Quest Diagnostics' (DGX) latest panels provide consumers a deeper look into their health, helping to prepare them for meaningful discussions with their healthcare providers

Here's Why You Should Retain Inogen (INGN) Stock for Now

Investors continue to be optimistic about Inogen (INGN) on its potential in the POC space and a strong product portfolio.

Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Stock Now

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.

MedTech Bigwigs in Spotlight as AI Revolutionizes Healthcare

MedTech player like Medtronic (MDT) are integrating artificial intelligence (AI) capabilities to aid therapeutic and diagnostic applications.

Dexcom (DXCM) Launches G6 Glucose Monitoring System in Canada

Dexcom (DXCM) announces the availability of standard of care in diabetes management - G6 CGM system - for type 1 and 2 patients with basal and bolus insulin or using an insulin pump in Canada.

Here's Why You Should Retain PerkinElmer (PKI) Stock Now

PerkinElmer (PKI) continues to gain from a solid product portfolio despite forex woes.

Catalent (CTLT) Inks Deal for Nasal Spray for Opioid Overdoses

Catalent's (CTLT) latest commercial supply agreement is expected to combat the opioid epidemic by making OTC naloxone more widely and easily accessible.

Medtronic (MDT) to Enhance AI Innovation With New Platform

Medtronic's (MDT) GI Genius intelligent endoscopy module is the first FDA-cleared, AI-assisted colonoscopy tool to help physicians detect polyps that can lead to colorectal cancer.

3 Reasons to Retain QuidelOrtho (QDEL) Stock in Your Portfolio

Investors continue to be optimistic about QuidelOrtho (QDEL) owing to its strong product portfolio.

Reasons to Retain West Pharmaceutical (WST) in Your Portfolio

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.

Quest Diagnostics (DGX) Advances Transplant Testing Service

These services by Quest Diagnostics (DGX) are available to recipients and living donors across the United States (excluding Alaska and Hawaii), broadening access for both donor and patient.

Here's Why You Should Retain Patterson Companies (PDCO) Stock

Investors are optimistic about Patterson Companies' (PDCO) strong product line.

Here's Why You Should Retain Abbott (ABT) Stock for Now

Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.

Neogen (NEOG) Receives New Label Claims for Viroxide Super

Neogen's (NEOG) Viroxide Super active constituents are potassium peroxymonosulfate and sodium chloride, which have been verified effective against multiple industry-relevant bacteria and viruses.

Three Reasons to Add Masimo (MASI) Stock to Your Portfolio

Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.

Chemed (CHE) Up on Roto-Rooter Sales Growth, Strong Admissions

Chemed (CHE) records increases in drain cleaning, plumbing, excavation and water restoration revenues within the Roto-Rooter branch commercial business.

Henry Schein (HSIC) Bolsters Dental Practices With AI Tools

Henry Schein (HSIC) integrates AI-enabled solutions, Dentrix Ascend Detect AI and Dentrix Ascend Voice, into its cloud-based dental software.

Syneos Health's (SYNH) New Microsoft Deal to Expand AI Usage

With the multi-year deal, Syneos Health (SYNH) aims to deliver technology and data solutions with Microsoft.

Merit Medical's (MMSI) New Launch to Boost its Product Suite

Merit Medical's (MMSI) latest addition to its Vascular portfolio is expected to significantly enhance patient outcomes.

NuVasive's (NUVA) Precice System Cleared for Pediatric Patients

NuVasive (NUVA) receives FDA 510(k) clearance for using the Precice limb lengthening system for treating pediatric patients.

Universal Health (UHS) Up 26% in 6 Months: More Room to Run?

Universal Health (UHS) is well-poised for growth on the back of improved patient volumes, acquisitions and robust cash-generating abilities.

Catalent (CTLT) Inks Deal for New & Effective Drug Delivery

Catalent (CTLT) will use Bhami Research Laboratory's technology to evaluate and develop drug-delivery system for high-concentration therapies, thereby increasing effectiveness.

Here's Why You Should Retain Accuray (ARAY) Stock for Now

Investors continue to be optimistic about Accuray (ARAY) owing to strong demand for its products.

BD's (BDX) New FDA Approval to Improve Vaginitis Testing

BD's (BDX) receipt of the latest FDA approval is likely to improve the detection and prevention of vaginitis.